133 related articles for article (PubMed ID: 32960142)
1. Digging Deeper into Breast Cancer Epigenetics: Insights from Chemical Inhibition of Histone Acetyltransferase TIP60
Idrissou M; Lebert A; Boisnier T; Sanchez A; Houfaf Khoufaf FZ; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
OMICS; 2020 Oct; 24(10):581-591. PubMed ID: 32960142
[TBL] [Abstract][Full Text] [Related]
2. TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer.
Judes G; Dubois L; Rifaï K; Idrissou M; Mishellany F; Pajon A; Besse S; Daures M; Degoul F; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Epigenomics; 2018 Nov; 10(11):1415-1430. PubMed ID: 30324811
[TBL] [Abstract][Full Text] [Related]
3. TIP60/P400/H4K12ac Plays a Role as a Heterochromatin Back-up Skeleton in Breast Cancer.
Idrissou M; Boisnier T; Sanchez A; Khoufaf FZH; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2020; 17(6):687-694. PubMed ID: 33099470
[TBL] [Abstract][Full Text] [Related]
4. The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.
Bassi C; Li YT; Khu K; Mateo F; Baniasadi PS; Elia A; Mason J; Stambolic V; Pujana MA; Mak TW; Gorrini C
Cell Death Differ; 2016 Jul; 23(7):1198-208. PubMed ID: 26915295
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.
Coffey K; Blackburn TJ; Cook S; Golding BT; Griffin RJ; Hardcastle IR; Hewitt L; Huberman K; McNeill HV; Newell DR; Roche C; Ryan-Munden CA; Watson A; Robson CN
PLoS One; 2012; 7(10):e45539. PubMed ID: 23056207
[TBL] [Abstract][Full Text] [Related]
6. Rational design and validation of a Tip60 histone acetyltransferase inhibitor.
Gao C; Bourke E; Scobie M; Famme MA; Koolmeister T; Helleday T; Eriksson LA; Lowndes NF; Brown JA
Sci Rep; 2014 Jun; 4():5372. PubMed ID: 24947938
[TBL] [Abstract][Full Text] [Related]
7. Quantifying Tip60 (Kat5) stratifies breast cancer.
McGuire A; Casey MC; Shalaby A; Kalinina O; Curran C; Webber M; Callagy G; Holian E; Bourke E; Kerin MJ; Brown JAL
Sci Rep; 2019 Mar; 9(1):3819. PubMed ID: 30846725
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Dagdemir A; Judes G; Lebert A; Echegut M; Karsli-Ceppioglu S; Rifaï K; Daures M; Ngollo M; Dubois L; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2016; 13(4):291-303. PubMed ID: 27365379
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Localization Is Not Required for Tip60 Tumor Suppressor Activity in Breast and Lung Cancer Cells.
Ravichandran P; Davis SA; Vashishtha H; Gucwa AL; Ginsburg DS
DNA Cell Biol; 2020 Nov; 39(11):2077-2084. PubMed ID: 33155839
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity.
Achour M; Fuhrmann G; Alhosin M; Rondé P; Chataigneau T; Mousli M; Schini-Kerth VB; Bronner C
Biochem Biophys Res Commun; 2009 Dec; 390(3):523-8. PubMed ID: 19800870
[TBL] [Abstract][Full Text] [Related]
11. Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
Lai Y; He Z; Zhang A; Yan Z; Zhang X; Hu S; Wang N; He H
Genes Genomics; 2020 Jun; 42(6):691-698. PubMed ID: 32399935
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of HDAC3 transcription by histone acetyltransferase TIP60 in colon cancer.
Lee SY; Park J; Seo SB
Genes Genomics; 2024 Jul; 46(7):871-879. PubMed ID: 38805168
[TBL] [Abstract][Full Text] [Related]
13. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
Epigenomics; 2013 Feb; 5(1):51-63. PubMed ID: 23414320
[TBL] [Abstract][Full Text] [Related]
14. TIP60 Inhibitor TH1834 Reduces Breast Cancer Progression in Xenografts in Mice.
Idrissou M; Judes G; Daures M; Sanchez A; El Ouardi D; Besse S; Degoul F; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
OMICS; 2019 Sep; 23(9):457-459. PubMed ID: 31487234
[No Abstract] [Full Text] [Related]
15. CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery.
Brauns-Schubert P; Schubert F; Wissler M; Weiss M; Schlicher L; Bessler S; Safavi M; Miething C; Borner C; Brummer T; Maurer U
EMBO Rep; 2018 Feb; 19(2):244-256. PubMed ID: 29335245
[TBL] [Abstract][Full Text] [Related]
16. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
17. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.
Xi Y; Shi J; Li W; Tanaka K; Allton KL; Richardson D; Li J; Franco HL; Nagari A; Malladi VS; Coletta LD; Simper MS; Keyomarsi K; Shen J; Bedford MT; Shi X; Barton MC; Kraus WL; Li W; Dent SYR
BMC Genomics; 2018 Feb; 19(1):150. PubMed ID: 29458327
[TBL] [Abstract][Full Text] [Related]
18. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Nuclear Receptor Function by Chromatin Modifying Factor TIP60.
Jaiswal B; Gupta A
Endocrinology; 2018 May; 159(5):2199-2215. PubMed ID: 29420715
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.
Tan CS; Ng YK; Ong WY
Mol Neurobiol; 2016 Aug; 53(6):3854-3872. PubMed ID: 26162318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
